Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection

Abstract

BackgroundLong COVID is associated with multiple symptoms and impairment in multiple organs. Cross-sectional studies have reported cardiac impairment to varying degrees by varying methodologies. Using cardiac MR (CMR), we investigated a 12-month trajectory of abnormalities in Long COVID.ObjectivesTo investigate cardiac abnormalities 1-year post-SARS-CoV-2 infection.Methods534 individuals with Long COVID underwent CMR (T1/T2 mapping, cardiac mass, volumes, function and strain) and multiorgan MRI at 6 months (IQR 4.3–7.3) since first post-COVID-19 symptoms. 330 were rescanned at 12.6 (IQR 11.4–14.2) months if abnormal baseline findings were reported. Symptoms, questionnaires and blood samples were collected at both time points. CMR abnormalities were defined as ≥1 of low left or right ventricular ejection fraction (LVEF), high left or right ventricular end diastolic volume, low 3D left ventricular global longitudinal strain (GLS), or elevated native T1 in ≥3 cardiac segments. Significant change over time was reported by comparison with 92 healthy controls.ResultsTechnical success of multiorgan and CMR assessment in non-acute settings was 99.1% and 99.6% at baseline, and 98.3% and 98.8% at follow-up. Of individuals with Long COVID, 102/534 (19%) had CMR abnormalities at baseline; 71/102 had complete paired data at 12 months. Of those, 58% presented with ongoing CMR abnormalities at 12 months. High sensitivity cardiac troponin I and B-type natriuretic peptide were not predictive of CMR findings, symptoms or clinical outcomes. At baseline, low LVEF was associated with persistent CMR abnormality, abnormal GLS associated with low quality of life and abnormal T1 in at least three segments was associated with better clinical outcomes at 12 months.ConclusionCMR abnormalities (left entricular or right ventricular dysfunction/dilatation and/or abnormal T1mapping), occurred in one in five individuals with Long COVID at 6 months, persisting in over half of those at 12 months. Cardiac-related blood biomarkers could not identify CMR abnormalities in Long COVID.Trial registration numberNCT04369807.

Multiparametric Cardiovascular MRI Assessment of Post-COVID Syndrome in Children in Comparison to Matched Healthy Individuals

“…In contrast to the acute COVID syndrome, which has been associated with a cytokine storm 31 along with elevated interleukin-6 and serum ferritin levels, 32 PCS is associated with normal levels of inflammatory cells, inflammatory biomarkers, and cardiac biomarkers, consistent with recent literature 1,33 . However, upon discriminating for frequency of abnormalities, a few children with PCS were identified with abnormalities for which 28% constitutes for NTproBNP.…”

Post-acute Cardiovascular Sequelae of COVID-19: an Overview of Functional and Imaging Insights

“…Another study showed that 19% of Long-COVID patients had abnormal CMR at baseline, including decreased LVEF, increased LV volumes, and increased T1. After a 1-year follow-up, up to 58% of these patients still had these findings [39].…”

Multiparametric MRI detects multi-organ impairment in patients with chronic myeloid neoplasms with normal serum biomarkers

“…At the baseline scan, the mean (SD) age of the patients was 55 years (13), with an equal split between male and females (Table S2). The mean (SD) age of the healthy control cohort ( n = 35) was 52 years (7) and the percentage of females was 66%. 58% (15/26 patients) were on active therapies, including hydroxycarbamide ( n = 4), pegylated interferon ( n = 2), and TKIs (imatinib n = 2; dasatinib n = 2; nilotinib n = 2; bosutinib n = 1).…”